What is the treatment for a calcium channel blocker overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Calcium Channel Blocker Overdose

Immediately administer intravenous calcium as the first-line antidote while simultaneously initiating high-dose insulin euglycemia therapy (HIET) for any patient with hemodynamic instability from calcium channel blocker overdose. 1

Initial Resuscitation and Assessment

  • Establish airway, breathing, and circulation following standard BLS/ACLS protocols 1
  • Place the patient on continuous cardiac monitoring with ECG to identify bradycardia, AV blocks, and dysrhythmias 1
  • Secure IV access, preferably central venous access if prolonged therapy is anticipated 1
  • Obtain baseline labs immediately: serum glucose, potassium, ionized calcium, and renal function 1
  • Recognize that severe overdoses can cause both vasoplegic shock from peripheral vasodilation and cardiogenic shock, regardless of whether the agent is a dihydropyridine or non-dihydropyridine CCB 2

First-Line Pharmacologic Therapy

Intravenous Calcium (Immediate Administration)

Administer calcium immediately for catecholamine-refractory shock as the initial antidote. 1

  • Bolus dose: 0.3 mEq/kg (equivalent to 0.6 mL/kg of 10% calcium gluconate OR 0.2 mL/kg of 10% calcium chloride) IV over 5-10 minutes 1
  • Continuous infusion: 0.3 mEq/kg per hour, titrated to hemodynamic response 1
  • Monitor serum ionized calcium levels throughout treatment and avoid severe hypercalcemia exceeding 2× the upper limit of normal 1
  • Calcium has proven efficacy in reversing depression of cardiac conduction and increasing blood pressure in CCB overdose 3

High-Dose Insulin Euglycemia Therapy (HIET)

Initiate HIET early for refractory shock and escalate if myocardial dysfunction persists. 1, 4

  • Initial bolus: 1 U/kg regular insulin with 0.5 g/kg dextrose 1, 4
  • Continuous insulin infusion: 0.5-1 U/kg/hr, titrated to clinical effect (can increase incrementally as needed) 1, 4
  • Dextrose infusion: 0.5 g/kg/hr, adjusted to maintain glucose 100-250 mg/dL 1
  • Glucose monitoring: Every 15 minutes initially during titration phase, then hourly once stable 1
  • Potassium monitoring: Every 1-2 hours during HIET to prevent hypokalemia 1
  • HIET works through a direct positive inotropic effect on myocardial contractility 4

Second-Line Therapies

Vasopressors and Inotropes

  • Dopamine has demonstrated efficacy in increasing blood pressure in CCB overdose and should be used for persistent hypotension 3
  • Consider IV glucagon if first-line therapies fail, though evidence shows mixed results in both animal and human studies 1

Bradycardia Management

  • Atropine may be attempted for symptomatic bradycardia or conduction disturbances, but expect limited efficacy (only 25% response rate in clinical studies) 1, 3
  • Use temporary pacing for unstable bradycardia or high-grade AV block WITHOUT significant myocardial dysfunction 1
  • Note that AV nodal depression is more common with verapamil overdoses compared to other CCBs 3

Advanced Rescue Therapies for Refractory Shock

Lipid Emulsion Therapy

  • Administer IV lipid emulsion for refractory shock or periarrest states 1

Extracorporeal Membrane Oxygenation (ECMO)

Consider ECMO for refractory shock with significant cardiogenic component or cardiac arrest. 1

  • Retrospective studies show improved outcomes in drug toxicity-related cardiac arrest with ECMO 1
  • Consensus supports ECMO for reversible causes like CCB toxicity 1
  • Consult cardiology or cardiothoracic surgery early for circulatory support options in severe cases 2

Novel Therapies

  • Levosimendan, a calcium sensitizer, may be considered in severe CCB poisoning when conventional therapies fail, as it improves contraction without increasing intracytosolic calcium concentration 5
  • Resin hemoadsorption/hemoperfusion using styrene resin filters has shown promise in case reports for enhanced drug clearance, though this remains experimental 6

Cardiac Arrest Management

  • Follow standard ACLS protocols with the addition of IV calcium bolus 1
  • Consider IV lipid emulsion therapy for cardiac arrest 1
  • Consider ECMO if available for cardiac arrest 1

Critical Monitoring Parameters

  • Continuous cardiac telemetry for rhythm and conduction abnormalities 1
  • Blood pressure monitoring with arterial line preferred for shock states 1
  • Serum glucose: Every 15 minutes initially, then hourly once stable 1
  • Serum potassium: Every 1-2 hours during HIET 1
  • Ionized calcium levels: During calcium infusions 1

Common Pitfalls to Avoid

  • Do not delay HIET initiation—it has become the mainstay of treatment in severe CCB overdose 7
  • Do not assume a patient has a perfusing blood pressure without verification; start CPR if pulseless 2
  • Do not overlook that high-concentration CCB overdoses lose receptor specificity, causing both bradycardia and peripheral vasodilation regardless of CCB subtype 2
  • Do not rely solely on atropine for bradycardia, as it has poor efficacy in CCB toxicity 1, 3

References

Guideline

Management of Calcium Channel Blocker Overdose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Calcium Channel Blocker Overdose.

Journal of education & teaching in emergency medicine, 2024

Guideline

High-Dose Insulin Euglycemia Therapy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Emergency management of calcium channel blocker overdose.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.